Publicacions - Fundació Institut d'Investigació en Ciències de la
Publicacions - Fundació Institut d'Investigació en Ciències de la
Publicacions - Fundació Institut d'Investigació en Ciències de la
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Codoñer FM, Pou C, Thiel<strong>en</strong> A, García F, Delgado R, Dalmau D, Santos JR, Buzón MJ, Martínez-Picado J,<br />
Alvarez-Tejado M, Clotet B, Ruiz L, Pare<strong>de</strong>s R.<br />
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure<br />
ANTIVIR RES 2010 Dec;88(3):281-6<br />
IF: 4,439<br />
Cunyat, F; Ruiz, L; Marfil, S; Puig, T; Bofill, M; B<strong>la</strong>nco, J; Clotet, B; Cabrera, C<br />
G<strong>en</strong>otypic and ph<strong>en</strong>otypic evolution of HIV type-1 protease during in vitro sequ<strong>en</strong>tial or concomitant<br />
combination of atazanavir and ampr<strong>en</strong>avir<br />
ANTIVIR THER 2010; , 15 (3) 431-436<br />
IF: 4,322<br />
Demetriou, VL; van <strong>de</strong> Vijver, DAMC; Kousiappa, I; Balotta, C; Clotet, B; Grossman, Z; Jorg<strong>en</strong>s<strong>en</strong>, LB;<br />
Lepej, SZ; Levy, I; Niels<strong>en</strong>, C; Paraskevis, D; Poljak, M; Roman, F; Ruiz, L; Schmidt, JC; Vandamme, AM;<br />
Van Laethem, K; Vercauter<strong>en</strong>, J; Kostrikis, LG<br />
Cellu<strong>la</strong>r HIV-1 DNA Levels in Drug S<strong>en</strong>sitive Strains Are Equival<strong>en</strong>t to Those in Drug Resistant Strains in<br />
Newly-Diagnosed Pati<strong>en</strong>ts in Europe<br />
PLOS ONE 2010; jun-08, 5 (6) -e10976<br />
IF: 4,411<br />
Dol<strong>la</strong>rd, SC; Butler, LM; Jones, AMG; Mermin, JH; Chidzonga, M; Chipato, T; Shiboski, CH; Bran<strong>de</strong>r, C;<br />
Mosam, A; Kiepie<strong>la</strong>, P; H<strong>la</strong>dik, W; Martin, JN<br />
Substantial regional differ<strong>en</strong>ces in human herpesvirus 8 seropreval<strong>en</strong>ce in sub-Saharan Africa: insights<br />
on the origin of the "Kaposi's sarcoma Belt"<br />
INT J CANCER 2010; nov-15, 127 (10) 2395-2401<br />
IF: 4,926<br />
Dore GJ, Soriano V, Rockstroh J, Kupfer B, Tedaldi E, Peters L, Neuhaus J, Puoti M, Klein MB, Mocroft A,<br />
Clotet B, Lundgr<strong>en</strong> JD; SMART INSIGHT study group.<br />
Frequ<strong>en</strong>t hepatitis B virus rebound among HIV-hepatitis B virus-coinfected pati<strong>en</strong>ts following<br />
antiretroviral therapy interruption.<br />
AIDS 2010 Mar 27;24(6):857-65.<br />
IF: 6,348<br />
Echeverría P, Negredo E, Carosi G, Gálvez J, Gómez JL, Ocampo A, Portil<strong>la</strong> J, Prieto A, López JC, Rubio R,<br />
Mariño A, Pedrol E, Vi<strong>la</strong>dés C, <strong>de</strong>l Arco A, Mor<strong>en</strong>o A, Bravo I, López-B<strong>la</strong>zquez R, Pérez-Alvarez N, Clotet<br />
B.<br />
Simi<strong>la</strong>r antiviral efficacy and tolerability betwe<strong>en</strong> efavir<strong>en</strong>z and lopinavir/ritonavir, administered with<br />
abacavir/<strong>la</strong>mivudine (Kivexa), in antiretroviral-naïve pati<strong>en</strong>ts: a 48-week, multic<strong>en</strong>tre, randomized study<br />
(Lake Study)<br />
ANTIVIR RES 2010 Feb;85(2):403-8. Epub 2009 Nov 24.<br />
IF: 4,439<br />
Esté JA, Cih<strong>la</strong>r T.<br />
Curr<strong>en</strong>t status and chall<strong>en</strong>ges of antiretroviral research and therapy.<br />
ANTIVIR RES 2010 Jan;85(1):25-33. Epub 2009 Dec 16.<br />
IF: 4,439<br />
Franco S. et al.<br />
Impact of antiretroviral therapy interruption on HCV diversity in pati<strong>en</strong>ts co-infected with HCV and HIV-<br />
Pàgina 50 <strong>de</strong> 148
Change language